Skip to main content

Find Clinical Trials

Home
Conditions
Refractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy

Clinical trial condition

Refractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy

Explore clinical trials studying Refractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Refractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy trial results

Active, Not Recruiting

Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor

NCT03607890

Conditions: Genomic Instability, MSI-H Tumors, Microsatellite Instability, +4 more
Locations: Cedars Sinai Medical Center Los Angeles, California, United States

Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

View Trial Details